Cargando…

Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol

INTRODUCTION: Asymmetric mandibular hypoplasia, microtia, tongue and laryngeal anomalies, and soft palate and facial nerve dysfunction are clinical features observed in children with craniofacial microsomia (CFM). Despite involvement of all these structures in hearing and speech, there is limited ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinter, Sara, Kotlarek, Katelyn, Meehan, Anna, Heike, Carrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980328/
https://www.ncbi.nlm.nih.gov/pubmed/36854602
http://dx.doi.org/10.1136/bmjopen-2022-069233
_version_ 1784899891615498240
author Kinter, Sara
Kotlarek, Katelyn
Meehan, Anna
Heike, Carrie
author_facet Kinter, Sara
Kotlarek, Katelyn
Meehan, Anna
Heike, Carrie
author_sort Kinter, Sara
collection PubMed
description INTRODUCTION: Asymmetric mandibular hypoplasia, microtia, tongue and laryngeal anomalies, and soft palate and facial nerve dysfunction are clinical features observed in children with craniofacial microsomia (CFM). Despite involvement of all these structures in hearing and speech, there is limited evidence reporting speech outcomes in this population. Systematic reviews of clinical and surgical interventions related to CFM have been published, but no methodological review of speech outcomes exists. This scoping review will summarise what is known about speech production in individuals with CFM as well as illustrate gaps in the existing body of literature that will guide future research. METHODS/ANALYSIS: This review will follow the methodological framework for scoping reviews first reported by Arksey & O’Malley and revised by Levac and others. Databases searched will include Ovid MEDLINE, EMBASE, CINAHL, PsycINFO and grey literature. Articles reporting any parameter of speech production in individuals with CFM will be considered for inclusion. Articles published in a language other than English will be excluded. Articles will be screened in three stages: (1) title review, (2) abstract review and (3) full text review. Ten per cent of articles will be rescreened by a second reviewer. Reference lists will be hand reviewed to identify additional relevant articles. Data charting will capture article metadata, study population and design, CFM diagnostic criteria, speech outcome measurement and key findings. The Preferred Reporting Systems for Systematic Reviews and Meta-Analyses Protocols-Extension for Scoping Reviews checklist will guide reporting of results. Descriptive analysis and data visualisation strategies will be used. ETHICS AND DISSEMINATION: Institutional review board approval is not required for a scoping review, as it does not directly involve human subjects. Results will be disseminated through peer-reviewed publication as well as conference presentation.
format Online
Article
Text
id pubmed-9980328
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-99803282023-03-03 Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol Kinter, Sara Kotlarek, Katelyn Meehan, Anna Heike, Carrie BMJ Open Rehabilitation Medicine INTRODUCTION: Asymmetric mandibular hypoplasia, microtia, tongue and laryngeal anomalies, and soft palate and facial nerve dysfunction are clinical features observed in children with craniofacial microsomia (CFM). Despite involvement of all these structures in hearing and speech, there is limited evidence reporting speech outcomes in this population. Systematic reviews of clinical and surgical interventions related to CFM have been published, but no methodological review of speech outcomes exists. This scoping review will summarise what is known about speech production in individuals with CFM as well as illustrate gaps in the existing body of literature that will guide future research. METHODS/ANALYSIS: This review will follow the methodological framework for scoping reviews first reported by Arksey & O’Malley and revised by Levac and others. Databases searched will include Ovid MEDLINE, EMBASE, CINAHL, PsycINFO and grey literature. Articles reporting any parameter of speech production in individuals with CFM will be considered for inclusion. Articles published in a language other than English will be excluded. Articles will be screened in three stages: (1) title review, (2) abstract review and (3) full text review. Ten per cent of articles will be rescreened by a second reviewer. Reference lists will be hand reviewed to identify additional relevant articles. Data charting will capture article metadata, study population and design, CFM diagnostic criteria, speech outcome measurement and key findings. The Preferred Reporting Systems for Systematic Reviews and Meta-Analyses Protocols-Extension for Scoping Reviews checklist will guide reporting of results. Descriptive analysis and data visualisation strategies will be used. ETHICS AND DISSEMINATION: Institutional review board approval is not required for a scoping review, as it does not directly involve human subjects. Results will be disseminated through peer-reviewed publication as well as conference presentation. BMJ Publishing Group 2023-02-28 /pmc/articles/PMC9980328/ /pubmed/36854602 http://dx.doi.org/10.1136/bmjopen-2022-069233 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Rehabilitation Medicine
Kinter, Sara
Kotlarek, Katelyn
Meehan, Anna
Heike, Carrie
Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol
title Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol
title_full Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol
title_fullStr Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol
title_full_unstemmed Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol
title_short Characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol
title_sort characterising the speech phenotype in individuals with craniofacial microsomia: a scoping review protocol
topic Rehabilitation Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980328/
https://www.ncbi.nlm.nih.gov/pubmed/36854602
http://dx.doi.org/10.1136/bmjopen-2022-069233
work_keys_str_mv AT kintersara characterisingthespeechphenotypeinindividualswithcraniofacialmicrosomiaascopingreviewprotocol
AT kotlarekkatelyn characterisingthespeechphenotypeinindividualswithcraniofacialmicrosomiaascopingreviewprotocol
AT meehananna characterisingthespeechphenotypeinindividualswithcraniofacialmicrosomiaascopingreviewprotocol
AT heikecarrie characterisingthespeechphenotypeinindividualswithcraniofacialmicrosomiaascopingreviewprotocol